Rectal formulation (RF) of tenofovir 1% gel

DRUG2 trials

Sponsors

Ian McGowan

Conditions

HIV Prevention

Phase 1

A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally

CompletedNCT01575405

Ian McGowanHIV Prevention

Start: 2013-03-31End: 2013-11-30Updated: 2013-11-07

An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations

CompletedNCT01575418

Ian McGowanHIV Prevention

Start: 2013-03-31End: 2013-11-30Updated: 2014-05-08

Related Papers

A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study)

PLoS ONE2015-05-0557 citations

Correlation between Compartmental Tenofovir Concentrations and an Ex Vivo Rectal Biopsy Model of Tissue Infectibility in the RMP-02/MTN-006 Phase 1 Study

PLoS ONE2014-10-2830 citations

A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1% gel (MTN-007).

2013-04-0381 citations